or Try an Advanced Search...

    H5n1 Clinical Trials Stocks List

    Symbol Grade Name % Change
    IBIO B iBio, Inc. -6.08
    NVAX F Novavax, Inc. 0.26
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Influenza Influenza Vaccine Medicine Seasonal Influenza Vaccination Vaccines Angioedema Anthrax Avian Influenza Biodefense Biotechnology Clinical Development Coronavirus Defense Products Deficiency Disorders Fabry Disease Hereditary Angioedema Human Papilloma Virus

    Related ETFs - A few ETFs which own one or more of the above listed H5n1 Clinical Trials stocks.

    Symbol Grade Name Weight
    GERM D ETFMG Treatments Testing and Advancements ETF 1.46
    XBI D SPDR S&P Biotech ETF 0.85
    TINY B ProShares Nanotechnology ETF 0.63
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.63
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.6
    View all H5n1 Clinical Trials ETFs...
    Compare ETFs
    Compare LABU to BBC Compare TINY to LABU Compare XBI to LABU

        H5n1 Clinical Trials Stocks Recent News

        Date Stock Title
        Apr 16 IBIO iBio files to sell 10.57M shares of common stock for holders
        Apr 15 NVAX Shah Capital calls for board shake-up at Novavax
        Apr 15 NVAX Shah Capital nominates two highly qualified independent director candidates for Novavax
        Apr 15 NVAX UPDATE 4-Novavax investor Shah Capital pushes for board shakeup
        Apr 13 NVAX Better Buy: Bluebird Bio Vs. Novavax
        Apr 12 NVAX Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Influenza Influenza Vaccine Medicine Seasonal Influenza Vaccination Vaccines Angioedema Anthrax Avian Influenza Biodefense Biotechnology Clinical Development Coronavirus Defense Products Deficiency Disorders Fabry Disease Hereditary Angioedema Human Papilloma Virus
        H5n1 Clinical Trials

        Browse All Tags